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iNTRoDuCTioN
An appropriate tracheal intubation requires the 
patient who goes under this procedure to allow the 
manipulation of cervical, maxillofacial and laryngeal 
pharynx in order to be able to visualize the glotis.1 
The use of neuromuscular relaxants is quite helpful 
when trying to attain this objective.2 Its use has 
become so widely applied that it is basically now 
the only technique known and taught to anesthe-
siologists.    
Such common use was the result of the fact 
that for many years there were no other alter-
natives in cases when the use of neuromuscle 
relaxants was contraindicated, or was not typi-
cally advised for those patients in which there is 
a need to avoid secondary effects of the muscular 
neuro-relaxant or  of those medicines used for its 
reversion.3 
With the intention to overcome such deficien-
cy, some techniques have been developed lately, 
orotracheal intubation without the use of 
muscle relaxant: propofol or etomidate in 
combination with remifentanil*
which  implies the conjugation of inhaled anes-
thetic agents, inductive  medicines and opiaceous 
drugs, applied in different ways without the use 
of the neuromuscle relaxant.1  Tyopental and pro-
pofol have been the most studied agents and this 
last has shown to have more mandibular relaxing 
capacity and laryngeal relaxing attenuation.4-11 
Available literature suggests that the remifen-
tanil is the most adequate opiaceous drugs to 
accompany the inductor, this due to its special 
pharmacokinetic characteristics and its excellent 
power.7,9-11 
Other inducting agents that could offer addi-
tional advantages in respect to the considerable 
hyper tensor and cardio-depressor effect of the 
propofol, have hardly been investigated.7 among 
them, the etomidate shows to be a reasonable 
alternative due to its minimal effects on cardio-
vascular functions. 13,14 
The purpose of this research is to evaluate the 
performance of the etomidate when associated to 
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reflex. At the moment and under the discretion 
of the anesthesiologist, an attempt was made to 
give respiratory assistance with a mask by using a 
Guedel oropharyngeal cannula.  Forty five seconds 
after the hypnotic agent was applied, post-induction 
vital signs were registered. Ninety (90) seconds of 
the hypnotic agent was applied, a laryngoscope 
was attempted using a Machintosch blade 3 and 
an endotracheal tube of 7.5 mm in women and 8 
m.m in men.
The anesthesiologist, who was not aware of the 
group the patient belonged to, graded the easiness 
of the respiratory assistance with facial mask, the 
mandibular relaxation degree, the laryngoscope 
according to Cormak-Lehane15, and evaluated the 
position of the vocal cords, the response of the 
patient (cough, extremities movements or both) 
during the orotracheal intubation and when in-
flating the pneumo-tamponade sleeve; this last 
one took place in a 5 second period. Intubating 
conditions were graded according to table 1.  
Conditions were classified as excellent, if all 
criteria were graded as 1; good, if the respiratory 
assistance with mask was graded as 1 and other 
criteria as 1 or 2; and bad, if any criteria were graded 
3 or 4. Patients that were not intubated in the first 
attempt, received 1,5 mg/kg of succinilcolina and 
30 seconds after they were intubated.  
To perform the analysis, the recommendation 
of the Conference and Consent of Copenhagen 
was followed, in which intubating conditions 
classified as excellent or good were clinically 
accepted and bad intubating conditions or the 
impossibility to carry it out were designated as 
clinically inacceptable. 16     
Mean Cardiac rate and blood pressure were re-
gistered in the following instances; 
a) When entering the surgery room  immediately 
before administration of the inducing medication 
(before the induction) 
b) Immediately before administration of the indu-
cing medication (before the induction)
c) 45 seconds after the hypnotic agent bolus (after 
the induction) 
d) Immediately after the intubation (after the intu-
bation), and 
e) Every minute during the following 5 minutes. 
Besides, other events were registered such as 
the presence of myoclonies and fasciculations, com-
plications such as larygeous spam bronchospam, 
thoracic wall rigidity. After the induction and while 
the evaluation time of the hemodynamic variables, 
the remifentanil as agents to provide adequate oro-
tracheal intubation conditions, when compared the 
conventional propofol-remifentanil scheme. 
mATERiAlS AND mETHoDS
After the approval given by the Ethic and In-
vestigation Committee of our institution, and the 
obtainment of the documented consent from each 
of the participants, there were 90 ASA I-II adult 
patients, of both sexes studied, who were randomly 
programmed for surgery using general anesthesia 
and that would require orotracheal intubation. Ex-
cluded were those with a history of Etanol or drug 
abuse, cardiovascular, hepatic or renal illness, a 
history of gastro-esophagi reflux, hiatal hernia, 
bronchial hyperactivity, corporal mass index of 
30 or superior, as well as patients classified with 
difficult airways.  
Patients were randomly distributed in three groups 
by means of a chart generated in the computer: 
Propofol group: control group 2 mg/kg of pro-• 
propofol y 3 μg/kg of remifentanil through an 
intra venous application.
Etomidate group 3: 0,3 mg/kg of etomidate and • 
3 μg/kg of remifentanil through an intravenous 
line.
Etomidate Group 4: 0,4 mg/kg of etomidate and • 
3μg/kg of remifentanil through  an intravenous 
application.
Patients were taken to the surgery rooms, where 
arterial pressure, continuous electrographic record, 
pulse oximetry and the capnography were monitored 
in a non-invasive conventional manner. They received 
0,03 mg/kg of midazolam through an intravenous 
line, 100% oxygen through a facial mask for a 5 minu-
te period, and an amount of 7 ml/kg of Ringer lactate 
solution was administered. At the end of these five 
minutes, vital signs previous to the induction were 
recorded and the anesthetic induction took place in 
accordance to the following scheme:  
Remifentanil, 3 μg/kg in 90 seconds through • 
intravenous line followed by
 lidocaine, 1mg/kg through intravenous line in • 
5 seconds, followed 
hypnotic through intravenous line (propofol or • 
etemidate) in 5 seconds.
 Medication was prepared by a chief nurse in the 
surgery room who was not part of the research. The 
level of unconsciousness was then determined due 
to response loss to orders and absence of palpebral 
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6mg of efedrina in bolus were administered through 
intravenous line when the mean blood pressure 
went down more than 30% from the initial value, 
or 0,5mg of atropine through intravenous line, if 
the heart rate was less than 45 beats per minute. 
After the orotracheal intubation, anesthesia was 
continued with sevofluorane intubation at 8% for 
2 minutes and later, at 1 MAC, 100% oxygen and 
adjusted mechanic respiratory assistance for the 
normocapnia maintenance were always used.  Any 
type of stimulus to the patient was always avoided 
during the research period. 
sample size
The number of patients needed to compare the 
studied groups and the control group in this clinical 
experiment was determined taking into account the 
following premises. 
That the probability of an alpha error (to • 
falsely conclude that there are differences 
between the studied group and the control 
group, when they do not really exist) would 
be less than 0,05.  
That the probability of a beta error (to falsely • 
conclude that there are not differences bet-
ween the studied and control group, when 
indeed there are) would be 0,20. 
That the obtained data in previous studies • 
show that the adminsitration of the propofol/
remintalin technic provides adequate intuba-
ting conditions on 93% of the patients.7 
We will consider as clinically important a di-• 
fference of 20% in respect to this value. 
By replacing these values in a formula of an • 
accepted sample size to compare portions in 
clinical experiments, we will have:  
 P1 (100-P1) + P2 (100 - P2)
 n = -------------------------------------- * f (α y β )
 (P1 - P2)2
 n=28
Therefore, each group should be integrated by 28 
patients; as we work with three groups, 84 patients 
were needed. 
statistical analysis 
Data was kept in a data base created for such 
purpose (File Maker Pro 6.0). Statistical analysis was 
presented as a mean ± standard deviation when the 
results were normally distributed and as a mean and 
range when they did not. Continuous demographic 
variables were analyzed through ANOVA.  Serial data 
for each group were analyzed though ANOVA (repeti-
tive measurements) followed by t matched tests with 
Bonferroni correction. To evaluate the differences 
among the group in terms of mean blood pressure 
and cardiac frequency, ANOVA was applied in one 
way followed by Tukey’s Post Hoc test when neces-
sary.  Categorical variables were analyzed with the 
Chi-square test. A value of p<0,05 was considered 
to be statistically significant. Statistical tests were 
carried out using the statistical package GraphPad 
Prism Version 4®. 
RESulTS 
There were not significant differences in the de-
mographic characteristics of the groups (table 2). All 
patients were able to receive respiratory assistance 
with facial mask after the induction; however, a 
difficult grading was given in one patient in the 
propofol group, in two patients in the etomidate 3 
group and in 2 patients in the etomidate 4 group 
(p=0,83).  Facts such as mask adjustment, teeth, 
etc., were discarded as causes of difficulty of the 
respiratory assistance in those patients. 
General orotracheal intubating conditions were 
classified as clinically acceptable in 100%, 74% and 
80% of the propofol, etomidate 3 and etomidate 4 
groups respectively (p=0,016) (figure 1). Discrimina-
ted analysis showed that five patients could not be 
intubated  in the first attempt, three of which belon-
ged to the etominate 3 group and two to the etomi-
date 4 group respectively (p=0,24). Main reasons for 
which the orotracheal intubation was unable to be 
performed were: inadequate mandibular relaxation 
[82 patients) and presence of closed vocal cords (3 
patients); after the application of succinilcolin, these 
individuals were easily intubated.  
No significant differences were found when indi-
vidually evaluating each of the components of the 
intubation condition scale: mandibular relaxation, 
easy laryngoscope, vocal cords position, cough pre-
sence, extremity movements, and response when 
inflating the pneumotamponade sleeve (figure 2).  
After anesthesia induction, decrease in mean 
blood pressure was significant in all groups 
(p<0,001), and such difference was maintained 
During the entire research period (figure 3). As we 
expected, this decrease was significantly higher in 
the propofol group as compared to the etomidate 3 
group (p=0,001); however, the statistical significan-
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ce disappeared when comparing the propofol and 
etomidate 4 groups (p=0,21).
From the moment of the patients’ entrance to 
the surgery room the cardiac frequency decreased 
in all groups, though only significant differences 
were found on blood pressure taken  after the in-
duction compared to the one taken at the moment 
of entrance (p<0,001 for propofol, etomidate 3 and 
etomidate 4). None of the patients was treated for 
bradicardy of less than 45 beats per minute. Due 
to the decrease of mean blood pressure higher than 
30% in relation to the entrance, it was necessary to 
intervene with 6 mg of efedrin through intravenous 
line in four patients of the propofol group, two pa-
tients from the etomidate 3 group and in one patient 
of the etomidate 4 group. In the total number of 
patients, oxygen saturations were obtained higher 
than 97%, in all stages of the research.  
DiSCuSSioN 
Our results show, that 3 μg/kg of remifentanil as-
sociated to 2 mg/kg of propofol, provide significantly 
better orotracheal intubating conditions, in the ab-
sence of a neuromuscular relaxant when compared 
to the administration of 3 μg/kg of remifentanil and 
diverse doses of etomidate 0,3 0r 0,4 mg/kg. 
These findings confirm the data reported by 
different researchers, who demonstrated that 
the use of propofol (2 a 2,5 mg/kg), associated to 
fentanil, alfentanil or remifentanil offer adequate 
orotracheal intubating conditions in patients in 
which no neuromuscular relaxant is used.7,9,11,17 
Propofol is consistently superior when compared 
to tiopental, but research is quite limited when it 
comes to comparing it to etomidate.7,11 The main 
reason to study the etomidate is that this medi-
cine is frequently  the number one medication 
choice in patients with diminished ventricular 
function and whose hemodynamic stability is 
especially important
In the case of the orotracheal intubation wi-
thout neuromuscular relaxant, the etomidate in 
combination with alfentanil was studied by Ste-
vens et al.18 They compared the conditions of intu-
bation in patients who were administered 40 µg/
kg of alfentanil followed by 2 mg/kg of propofol, 
4 mg/kg of tiopental or 0,3 mg/kg of etomidate, 
which provided adequate oratracheal intubating 
conditions. On the contrary, Erhan et al. reported 
that 2 mg/kg of propofol were superior to 6 mg/
kg of tiopental and 0,3 mg/kg of etomidate when 
combined with 3 µg/kg of remifentalin.7 Those 
authors found orotracheal intubating conditions 
clinically acceptable in 93% of the patients of the 
propofol group, 66,7% in the tiopental group and 
only in 40% of the etomidate group. Our finding 
partially coincide with such investigation, due 
to the fact that the advantages of the propofol 
were confirmed and that it provided adequate 
orotracheal intubation conditions in 100% of our 
patients
In our research, 0,3 mg/kg of etomidate provi-
ded acceptable orotracheal intubating conditions 
in 74,2% of the patients, without observing a sig-
nificant  improvement when increasing the dosage 
to 0,4%mg/kg; in this group there were accepta-
ble clinical orotracheal intubation conditions in 
80% of the patients. The best response we were 
able to observe with etomidate when compared 
to those findings made by Erhan et al.7 could be 
the result of using intravenous lidocaine. A cough 
suppressing effect because of intravenous lido-
caine is recognized, though its mechanism has 
not been clarified.5 It has been suggested that it 
could be a reaction from suppressing the response 
of the peripheral receptors of the cough reflex, 
in the trachea as well as in the hypopharinx, by 
depression of the cerebral stem or by an increase 
on the depth of the general anesthesia.20,21  
We do not know of studies that evaluate a 
dosage of 0,4 mg/kg etomidate in the case of the 
orotracheal intubation without neuromuscular 
relaxant. Etomidate can be administered safely 
in a higher dose than the one usually used du-
ring the induction, in an effort to maximize the 
anesthetic depth and avoid by this the response to 
the orotracheal intubation, 20  however results did 
not show any improvement in terms of orotracheal 
intubation conditions when incrementing the  dose 
of the  medicine
As expected, mean blood pressure decreased 
significantly after anesthesia induction and this 
decrease was higher in patients that belonged to 
the etomidate 3 group, than in the group in which 
hemodynamic values remained more stable.  The 
0,4 mg/kg etomidate dose increase produced a 
decrease in mean blood pressure, slightly higher 
when compared to the 0,3 mg/kg group. This 
finding, though interesting, has been previously 
reported; observations carried out with etomida-
te 0,3 to 0,6 mg/kg range have showed modest 
decreases (related to the dose) of mean blood 
pressure and of the left ventricular function, wi-
thout cardiac frequency change, cardiac index or 
filling pressures.23 
Even though, it is clear that the use of etomidate 
offers more favorable hemodynamic conditions, the 
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observed tendency reflects its low capacity to pro-
vide acceptable intubating conditions. It is evident 
that the increase of etomidate dose, when trying to 
increase its hypnotic power, did not influence the 
intubating conditions and, on the contrary, affected 
its capacity to produce a better hemodynamic stabi-
lity.  It is possible then that the differences between 
the hypnotic power from propofol and etomidate are 
centered in their action mechanism and intrinsic 
effect and not in their dose.   
In conclusion, our results show the superiority 
of the propofol-remifentanil scheme, to provide 
acceptable clinical conditions of orotracheal intu-
bation without muscle relaxant, even though they 
produce a hypotensor effect, higher than the one 
observed with the use of etomidate on the usual 0,3 
mg/kg dose. Higher etomidate dose do not contri-
bute any advantage with respect to the intubating 
conditions and, on the contrary, its hemodynamic 
behavior is closer to that of the propofol. 
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